It was shown that a vaccine composed of monocyte-derived autologous Th17-inducing DCs pulsed with folate receptor alpha (FRα) epitopes was highly immunogenic and promoted the prolongation of the remission period in patients with ovarian cancer. This evidence concerns the gene FOLR1 and ovarian cancer.